New Results
Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype
View ORCID ProfileAlbert Rübben, Renate Ursula Wahl, Thomas Eggermann, Edgar Dahl, Nadina Ortiz-Brüchle, Claudio Cacchi
doi: https://doi.org/10.1101/844647
Albert Rübben
1Department of Dermatology, RWTH Aachen University, Aachen, Germany
Renate Ursula Wahl
1Department of Dermatology, RWTH Aachen University, Aachen, Germany
Thomas Eggermann
2Institute of Human Genetics, RWTH Aachen University, Aachen, Germany
Edgar Dahl
3Institute of Pathology, RWTH Aachen University, Aachen, Germany
4RWTH centralized Biomaterial Bank (RWTH cBMB), Medical Faculty, Aachen, Germany
Nadina Ortiz-Brüchle
3Institute of Pathology, RWTH Aachen University, Aachen, Germany
4RWTH centralized Biomaterial Bank (RWTH cBMB), Medical Faculty, Aachen, Germany
Claudio Cacchi
3Institute of Pathology, RWTH Aachen University, Aachen, Germany
Article usage
Posted November 15, 2019.
Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype
Albert Rübben, Renate Ursula Wahl, Thomas Eggermann, Edgar Dahl, Nadina Ortiz-Brüchle, Claudio Cacchi
bioRxiv 844647; doi: https://doi.org/10.1101/844647
Subject Area
Subject Areas
- Biochemistry (11753)
- Bioengineering (8752)
- Bioinformatics (29201)
- Biophysics (14974)
- Cancer Biology (12100)
- Cell Biology (17413)
- Clinical Trials (138)
- Developmental Biology (9422)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18309)
- Genetics (12245)
- Genomics (16804)
- Immunology (11869)
- Microbiology (28098)
- Molecular Biology (11596)
- Neuroscience (60975)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)